Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
The Daily Overview on MSN
3 under-the-radar perks of opening a business credit card
Opening a business credit card is often framed as a way to separate expenses and earn basic rewards, but the real value can ...
We chose H&R Block as our best overall online tax service because of its transparent pricing, easy-to-use platform, and ...
A Brookeland man lost everything when fire destroyed his camper home Wednesday. His family believes fireworks set off nearby ...
Kalen DeBoer is a historical marker in the growth of Indiana football, which now has a flavor of Nick Saban's Alabama thanks ...
The New Hampshire Department of Employment Security is much more than a typical unemployment office, and they’re helping ...
Mongabay News on MSNOpinion
‘The bargain of the century’: An economist’s vision for expanding clean energy access in Africa
Many observers see industrialization as the key to boosting clean electricity access for people living in Africa and across ...
Sonoma Valley Unified School District students made improvements in college and career readiness, suspensions and chronic ...
Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have captured real-time images showing how a key brain enzyme organizes itself to help memory formation. Their study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback